One (1) new case of COVID-19 was identified out of 431 tests performed on Monday, March 8.
To date, there have been a total of 7,752 officially reported cases of COVID-19 with 133 deaths, 21 cases in active isolation, and 7,598 not in active isolation.
|
TODAY’S CAR SCORE |
0.1 |
The COVID Area Risk (CAR) Score accounts for the incidence of new cases, how well current testing identifies these cases, and the rate of spread. The ideal long-term goal is to sustain a CAR Score of 2.5 or less, which has been shown to correlate with very low to zero COVID-related hospitalizations and deaths.
The following tables provide COVID-19 test results reported to the JIC on Tuesday, March 9, and reflects results from Monday, March 8:
|
COVID-19 CASE COUNT |
TOTAL |
NEW CASES REPORTED TODAY |
PAST 7 DAYS |
|
COVID-19 CASES: |
7,752 |
1 |
10 |
|
CONFIRMED CASES: |
7,543 |
1 |
10 |
|
PROBABLE CASES: |
209 |
0 |
0 |
|
COVID-19 TESTING ON GUAM |
TOTAL |
NEW TESTS REPORTED TODAY |
7-DAY % POSITIVE |
|
DIAGNOSTIC TESTS |
131,158 |
431 |
0.7% |
|
MOLECULAR TESTS |
121,601 |
431 |
0.7% |
|
ANTIGEN TEST |
9,557 |
0 |
0.3% |
|
SEROLOGY TESTS |
358 |
0 |
100% |
|
CASE BREAKDOWN |
|||
|
STATUS |
TOTAL |
CURRENT ISOLATION LOCATION |
TOTAL |
|
COVID-19 Death |
133 |
Hospital |
1 |
|
Active Isolation |
21 |
Home |
10 |
|
Not In Isolation |
7,598 |
Isolation Facility |
4 |
|
Civilian |
7,360 |
Military |
6 |
|
Military Service Member |
392 |
|
COVID HOSPITAL CENSUS |
Guam Memorial Hospital |
Guam Regional Medical City |
U.S. Naval Hospital |
TOTAL |
|
COVID ADMISSION |
1 |
0 |
0 |
1 |
|
IN ICU |
0 |
0 |
0 |
0 |
|
ON VENTILATOR |
0 |
0 |
0 |
0 |
The following provides preliminary COVID-19 vaccinations reported to the JIC on Tuesday, March 9, for vaccinations administered from December 17 to March 8:
|
Vaccine Maker |
1st Doses Administered |
2nd Doses Administered |
Total Doses Administered |
Individuals Fully Immunized |
|
Pfizer-BioNTech |
17,218 |
12,845* |
30,063 |
12,845 |
|
Moderna |
16,033** |
9,100*** |
25,133 |
9,100 |
|
Johnson & Johnson Janssen |
– |
– |
0 |
0 |
|
TOTALS: |
33,251 |
21,945 |
55,196^ |
21,945 |
*Administering second doses of Pfizer-BioNTech COVID-19 vaccinations began on January 4, 2021.
**Administering first doses of Moderna COVID-19 vaccinations began on January 8, 2021.
***Administering second doses of Moderna COVID-19 vaccinations began on January 29, 2021.
|
Total Doses Administered |
Total Doses Allotted |
% Administered |
Doses Remaining |
|
55,196^ |
87,860^^ |
62.82% |
32,664 |
^As of March 8, 2021. Total doses administered and allotted doses differ as vaccinators were able to draw additional doses per vial. Additionally, the U.S. Food and Drug Administration’s February 25, 2021 revision of their Fact Sheet relative to the Pfizer-BioNTech Emergency Use Authorization now states “After dilution, one vial contains 6 doses of 0.3 mL. Vial labels and cartons may state that after dilution, a vial contains 5 doses of 0.3 mL. The information in this Fact Sheet regarding the number of doses per vial after dilution supersedes the number of doses stated on vial labels and cartons.” | ^^Reflects the previous allocation total of 86,560 and last received allocation of 1,300 Johnson & Johnson Janssen vaccines on March 8, 2021.
(JIC Release No. 596)
##
